Concepedia

Gabriela Velasco-Loyden

GV

Statistics

Publications

8

Citations

316

H-Index

8

Active since

1999

Affiliations

Universidad Nacional Autónoma de México(Current)

National Institute of Genomic Medicine

Gabriela Velasco-Loyden is an author at Universidad Nacional Autónoma de México specializing in pharmacology, liver disease, and life sciences.

Publications per year

1999–2019

8

Publications

8

The Shedding of Betaglycan Is Regulated by Pervanadate and Mediated by Membrane Type Matrix Metalloprotease-1

Gabriela Velasco-Loyden, Joaquı́n Arribas, Fernando López‐Casillas · Journal of Biological Chemistry · 2004 · 151 citations · Full text

, , +9

Hyperkalemic periodic paralysis M<sub>1592</sub>V mutation modifies activation in human skeletal muscle Na<sup>+</sup> channel

Cecilia Rojas, Alan Neely, Gabriela Velasco-Loyden et al. · American Journal of Physiology-Cell Physiology · 1999 · 41 citations

, , +17

An adenosine derivative compound, IFC305, reverses fibrosis and alters gene expression in a pre-established CCl4-induced rat cirrhosis

Julio Isael Pérez‐Carreón, Lidia Martínez-Pérez, Maria Loredo et al. · The International Journal of Biochemistry & Cell Biology · 2009 · 27 citations

, , +14

Cancer chemoprevention by an adenosine derivative in a model of cirrhosis-hepatocellular carcinoma induced by diethylnitrosamine in rats

Gabriela Velasco-Loyden, Lidia Pérez-Martínez, Susana Vidrio-Gómez et al. · Tumor Biology · 2017 · 25 citations · Full text

, , +17

Prevention of in vitro hepatic stellate cells activation by the adenosine derivative compound IFC305

Gabriela Velasco-Loyden, Julio Isael Pérez‐Carreón, José Agüero et al. · Biochemical Pharmacology · 2010 · 23 citations

, , +11

1–5 of 8